Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson's disease

被引:10
|
作者
Ali, Shaheen Jafri [1 ]
Rajini, Padmanabhan Sharda [1 ]
机构
[1] Cent Food Technol Res Inst, CSIR, Dept Food Protectants & Infestat Control, Mysore 570020, Karnataka, India
关键词
Dopamine; mice; monocrotophos; oxidative stress; Parkinson's disease; striatum; tyrosine hydroxylase; ACUTE CHLORPYRIFOS EXPOSURE; INDUCED OXIDATIVE STRESS; ALPHA-SYNUCLEIN; TIME-COURSE; VITAMIN-C; PESTICIDES; ACETYLCHOLINESTERASE; MPTP; DAMAGE; BRAIN;
D O I
10.1177/0748233714547733
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our earlier study had shown that low concentrations of monocrotophos (MCP) elicited dopaminergic features of Parkinson's disease (PD) in the nematode Caenorhabditis elegans. In the present study, the effect of low doses of MCP on the striatal dopaminergic neurons was investigated using the mouse model system. MCP was initially screened for its ability to cause any neurobehavioral deficits and alterations in the dopaminergic system in Swiss albino mice, aged 8 weeks and weighing 25-30 g, with repeated doses at 0.3 and 0.6 mg/kg body weight (b.w.)/day for 7 days and 30 days. Mice were treated with four intraperitoneal injections for every 2 h with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at the dosage of 14 mg/kg b.w. MCP was administered to these mice at the above-mentioned doses for 7 days. Mice administered with MCP alone revealed a significant < 0.05) reduction in the dopamine (DA) content at both 7 and 30 days and showed a significant (p < 0.05) increase in neurobehavioral deficits. Interestingly, when MCP was administered for 7 days to MPTP-treated mice, further significant decrease in both DA content and increase in neurobehavioral deficits were apparent. The extent of reactive oxygen species and lipid peroxidation were markedly increased, while the ratio of reduced to oxidized glutathione levels were significantly decreased (p < 0.05) in the treated mice as compared to the control. Significant histopathological alterations and a marked reduction in the number of tyrosine hydroxylase positive cells were evident in striatum of mice treated with higher doses of MCP. These changes were comparable to that seen in mice treated with MPTP and post-administered lower doses of MCP. Our findings suggest that MCP per se has the propensity to induce pathological changes in the dopaminergic neurons as well as augment the degeneration in a compromised nigrostriatal system such as that in PD.
引用
收藏
页码:1153 / 1165
页数:13
相关论文
共 50 条
  • [31] Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease
    Thadathil, Nidheesh
    Xiao, Jianfeng
    Hori, Roderick
    Alway, Stephen E.
    Khan, Mohammad Moshahid
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2021, 16 (03) : 667 - 678
  • [32] The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease
    Bayram, Ece
    Kaplan, Nikki
    Shan, Guogen
    Caldwell, Jessica Z. K.
    AGING NEUROPSYCHOLOGY AND COGNITION, 2020, 27 (04) : 581 - 594
  • [33] The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea
    Huot, Philippe
    Levesque, Martin
    Parent, Andre
    BRAIN, 2007, 130 : 222 - 232
  • [34] Temporal trajectory model for dopaminergic input to the striatal subregions in Parkinson?s disease
    Kim, Han-Kyeol
    Lee, Myung Jun
    Yoo, Han Soo
    Lee, Jae Hoon
    Ryu, Young Hoon
    Lyoo, Chul Hyoung
    PARKINSONISM & RELATED DISORDERS, 2022, 103 : 42 - 49
  • [35] Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease
    Kim, Wonju
    Im, Mi Jung
    Park, Cheol Hyoung
    Lee, C. Justin
    Choi, Sukwoo
    Yoon, Bong-June
    NEUROSCIENCE LETTERS, 2013, 557 : 95 - 100
  • [36] Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson’s Disease
    Nicoletta Schintu
    Lucia Frau
    Marcello Ibba
    Arianna Garau
    Ezio Carboni
    Anna R. Carta
    Neurotoxicity Research, 2009, 16 : 127 - 139
  • [37] Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease
    Mudo, Giuseppa
    Makela, Johanna
    Di Liberto, Valentina
    Tselykh, Timofey V.
    Olivieri, Melania
    Piepponen, Petteri
    Eriksson, Ove
    Malkia, Annika
    Bonomo, Alessandra
    Kairisalo, Minna
    Aguirre, Jose A.
    Korhonen, Laura
    Belluardo, Natale
    Lindholm, Dan
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2012, 69 (07) : 1153 - 1165
  • [38] Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease
    Bourque, Melanie
    Morissette, Marc
    Cote, Melissa
    Soulet, Denis
    Di Paolo, Therese
    NEUROBIOLOGY OF AGING, 2013, 34 (03) : 887 - 901
  • [39] TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease
    Shao, Qian-hang
    Chen, Ying
    Li, Fang-fang
    Wang, Shuo
    Zhang, Xiao-ling
    Yuan, Yu-he
    Chen, Nai-hong
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (12) : 1503 - 1512
  • [40] Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease
    Shimoji, M
    Zhang, L
    Mandir, AS
    Dawson, VL
    Dawson, TM
    MOLECULAR BRAIN RESEARCH, 2005, 134 (01): : 103 - 108